SI — Shoulder Innovations, Inc. stock price, charts and financials

QT81Shoulder Innovations, Inc.

Shoulder Innovations, Inc. (NYSE: SI) is a Healthcare company in the Medical - Specialties industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
22.38
-0.36-1.58%
OverviewShort InterestFilings
SIQT81Shoulder Innovations, Inc.·NYSE
22.38-1.58%
TA
Loading chart...
Screen all →
MOBI+1.52%$11.35MASS+5.12%$8.42STE+1.86%$232.64ALC+1.84%$70.21SYRE-3.46%$94.93ATR+2.10%$136.77PRAX-0.75%$305.51IONS+5.25%$54.49
Snapshot
Index-P/E-EPS (ttm)-2.17Insider Own13.61%Shs Outstand20.74MPerf Week11.42%
Market Cap471.59MForward P/E-EPS next Y-1.31Insider Trans-0.52%Shs Float18.12MPerf Month10.28%
Enterprise Value475.11MPEG0.11EPS next Q-0.46Inst Own-Short Float1.15%Perf Quarter77.80%
Income-44.23MP/S8.75EPS this Y21.10%Inst Trans-Short Ratio1.92Perf Half Y59.36%
Sales53.89MP/B3.53EPS next Y23.26%ROA-27.49%Short Interest208.43KPerf YTD59.02%
Book/sh-P/C-EPS next 5Y-ROE-35.31%52W High24.21 -7.56%Perf Year-
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-20.92%52W Low10.75 108.24%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y-Gross Margin75.48%Volatility7.19% 6.94%Perf 5Y-
Dividend TTM-EV/Sales8.82EPS Y/Y TTM-181.82%Oper. Margin-57.48%ATR (14)1.43Perf 10Y-
Dividend Ex-Date-Quick Ratio10.04Sales Y/Y TTM68.75%Profit Margin-81.78%RSI (14)58.71Recom2.00
Dividend Gr. 3/5Y-Current Ratio11.81EPS Q/Q-115.42%SMA205.28%Beta0.40Target Price23.00
Payout0.00%Debt/Eq0.11Sales Q/Q70.00%SMA5019.70%Rel Volume0.70Prev Close22.74
Employees75LT Debt/Eq0.10EarningsSep 08SMA20049.92%Avg Volume112.46KPrice22.38
IPO DateJul 31, 2025Option/ShortYes / YesEPS/Sales Surpr.-0.10% 14.94%Net Debt/EBITDA-0.09Volume79,167Change-1.58%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-28-26InitiatedUBSBuy$27
May-08-26ReiteratedPiper SandlerOverweight$18 → $19
Dec-02-25ReiteratedMorgan StanleyOverweight$18 → $23
Aug-25-25InitiatedMorgan StanleyOverweight$13 → $18
Aug-25-25InitiatedJefferiesBuy$19
Aug-25-25InitiatedPiper SandlerOverweight$18
Aug-25-25InitiatedGoldman SachsBuy$10 → $20
Jan-09-23ReiteratedMorgan Stanley$24 → $13
Jan-09-23ReiteratedWedbush$45 → $9.00
Jan-09-23ReiteratedGoldman Sachs$35 → $10
Latest News
Company

Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
Total Revenue54473219
Cost of Goods Sold Incl. D&A131174
Gross Profit41362415
Selling, General and Administrative Excl. Other61553523
Research and Development10843
Other Operating Expense2-100
Operating Income-31-26-15-11
Interest Expense-1011
Unusual Expense
————
Non-Operating Income (Expense)-14-140-1
Net Income Before Taxes-44-40-16-13
Income Taxes
0000
Consolidated Net Income-44-40-16-13
Net Income From Continuing Operations-44-40-16-13
Net Income-44-40-16-13
EPS (Recurring)-2.17-1.96-0.77-0.63
EPS (Basic, Before Extraordinaries)-2.17-1.96-0.77-0.63
EPS (Diluted)-2.17-1.96-0.77-0.63
EBITDA-41-37-12-10
Other After Tax Adjustments
————
Stock Option Compensation Expense
————
Price To Earnings Ratio
————
Price To Sales Ratio8.706.39——
Gross Margin75.9376.6075.0078.95
Operating Margin-57.41-55.32-46.88-57.89
Net Margin-81.48-85.11-50.00-68.42
Shares Outstanding21212020
Market Capitalization470300——
Operating Lease Expense
————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$26.24$21.93$17.63$13.33$9.02● Close Price0.00K93.56K187.13K280.69K374.25KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Ahearn Matthew FraserChief Operating OfficerJun 15 '26Sale18.844,14478,070269,176Jun 16
Ahearn Matthew FraserChief Operating OfficerJun 12 '26Sale18.6815,856296,185273,320Jun 16
Ball Robert JosephCEO & Executive ChairmanApr 30 '26Option Exercise2.4810,00024,804300,018Apr 30
Ahearn Matthew FraserChief Operating OfficerApr 20 '26Option Exercise2.7321,66459,170286,765Apr 21
Points Jeffrey S.Chief Financial OfficerMar 13 '26Buy15.002,00030,00070,785Mar 17
Points Jeffrey S.Chief Financial OfficerMar 13 '26Option Exercise2.4813,26432,90068,785Mar 17
BUCKMAN PAULDirectorMar 13 '26Option Exercise2.2645,606103,12165,710Mar 17
Buchholz RichardDirectorMar 13 '26Buy14.841,00014,84013,666Mar 17
Ball Robert JosephCEO & Executive ChairmanMar 13 '26Buy15.182,20033,392278,866Mar 17
Ball Robert JosephCEO & Executive ChairmanFeb 06 '26Option Exercise2.4212,06229,132276,666Feb 10
Points Jeffrey S.Chief Financial OfficerDec 12 '25Buy14.981,00515,05554,445Dec 15
Ball Robert JosephCEO & Executive ChairmanDec 12 '25Buy14.893,90058,075118,457Dec 15
Ball Robert JosephCEO & Executive ChairmanDec 11 '25Buy14.833,30048,934114,557Dec 15
Points Jeffrey S.Chief Financial OfficerDec 11 '25Buy14.6599514,57753,440Dec 15
Fraher KathleenChief Transition OfficerNov 19 '23Option Exercise0.001,203012,571Nov 21
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.